Results 101 to 110 of about 22,288 (223)

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome

open access: yes, 2016
Wing H Chung,1 Elon H C van Dijk,1 Danial Mohabati,1 Greet Dijkman,1 Suzanne Yzer,2 Eiko K de Jong,3 Sascha Fauser,4 Reinier O Schlingemann,5–7 Carel B Hoyng,3 Camiel J F Boon1,5 1Department of Ophthalmology, Leiden University Medical Center ...
Fauser S   +9 more
core  

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels

open access: yesClinical Ophthalmology, 2013
Yousif Subhi, Amardeep Singh, Mads Krüger Falk, Torben Lykke SørensenDepartment of Ophthalmology, Clinical Eye Research Unit, Copenhagen University Hospital Roskilde and the University of Copenhagen, Copenhagen, DenmarkPurpose: Association of
Subhi Y   +3 more
doaj  

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review

open access: yes, 2016
Shiqi Yang,1 Jingke Zhao,1 Xiaodong Sun1–3 1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 2Eye Research Institute of Shanghai Jiao Tong University, 3Shanghai Key Laboratory of Fundus ...
Sun X, Yang S, Zhao J
core  

Durability and Efficacy of Faricimab in Treatment-Resistant Retinal Edema Utilizing “Real-World” Dosing Regimens

open access: yesJournal of Ophthalmology
Conclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant   +7 more
doaj   +1 more source

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

open access: yesClinical Ophthalmology, 2014
Paul Hahn Duke Eye Center, Duke University Medical Center, Durham, NC, USA Abstract: Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy in vitrectomized eyes remains a challenge due to the reduced half-life of these agents ...
Hahn P
doaj  

Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes

open access: yes, 2016
Ana Catarina Pedrosa,1 Adriana Reis-Silva,2 João Pinheiro-Costa,1,3 João Beato,1 Paulo Freitas-da-Costa,1,3 Manuel S Falcão,1,2 Fernando Falcão-Reis,1,2 Ângela Carneiro1,2 1Department of Ophthalmology, Hospital de S ...
Beato J   +7 more
core  

Neovascular age-related macular degeneration : incidence, prevalence, treatment outcomes and quality of life [PDF]

open access: yes
Age-related macular degeneration (AMD) is a common cause for irreversible visual impairment in developed countries. Intravitreal vascular endothelial growth factor (VEGF) inhibitors have revolutionized the visual prognosis of neovascular AMD (nAMD). This
Korva-Gurung, Ida
core   +1 more source

Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development

open access: yes, 2015
Aniruddha Agarwal, William R Rhoades, Mostafa Hanout, Mohamed Kamel Soliman, Salman Sarwar, Mohammad Ali Sadiq, Yasir Jamal Sepah, Diana V Do, Quan Dong Nguyen Stanley M Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA ...
Sepah YJ   +8 more
core  

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes

open access: yes, 2022
Debdulal Chakraborty,1 Aniruddha Maiti,2 Jay U Sheth,3 Soumen Mondal,1 Subhendu Boral,1 Krishnendu Nandi,4 Tushar Kanti Sinha,1 Arnab Das1 1Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India; 2Department of ...
Sheth JU   +7 more
core  

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives

open access: yes, 2015
James E Neffendorf, Timothy L Jackson Department of Ophthalmology, School of Medicine, King’s College London, London, United Kingdom Abstract: Neovascular age-related macular degeneration is a leading cause of blindness in the developed world ...
Jackson TL, Neffendorf JE
core  

Home - About - Disclaimer - Privacy